EP3518871A1 - Agents de traitement capillaire à effet conditionnant amélioré et résistants au lavage - Google Patents

Agents de traitement capillaire à effet conditionnant amélioré et résistants au lavage

Info

Publication number
EP3518871A1
EP3518871A1 EP17748435.9A EP17748435A EP3518871A1 EP 3518871 A1 EP3518871 A1 EP 3518871A1 EP 17748435 A EP17748435 A EP 17748435A EP 3518871 A1 EP3518871 A1 EP 3518871A1
Authority
EP
European Patent Office
Prior art keywords
weight
hair treatment
hair
composition according
preferred
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP17748435.9A
Other languages
German (de)
English (en)
Inventor
Volker Scheunemann
Erik Schulze Zur Wiesche
René KROHN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP3518871A1 publication Critical patent/EP3518871A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/737—Galactomannans, e.g. guar; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/004—Preparations used to protect coloured hair

Definitions

  • the invention relates to hair treatment compositions, in particular shampoos and so-called conditioners, with a combination of active ingredients for gentle and effective care of the hair.
  • hair treatment compositions in particular shampoos and so-called conditioners
  • active ingredients for gentle and effective care of the hair.
  • care products affect the natural structure and properties of the hair.
  • the wet and dry combability of the hair, the hold and the fullness of the hair can be optimized or the hair can be protected from increased splits following such care treatments.
  • the hair is treated with special active ingredients, for example quaternary ammonium salts or special polymers, usually in the form of a rinse.
  • special active ingredients for example quaternary ammonium salts or special polymers, usually in the form of a rinse.
  • this treatment improves the combability, the hold and the fullness of the hair and reduces the splitting rate.
  • multifunctional cosmetic products are known in the prior art.
  • these include the so-called “2 in 1" shampoos, which not only cleanse the hair, but also condition it.
  • These products are highly appreciated by the consumer because of their product performance, at least one process step, for example, conditioning with a classical hair conditioner; unnecessary.
  • the term "undesired change” is understood to mean the fading or bleeding and loss of color brilliance of the hue of the hair as a result of the respective dyeing.Environmental influences and / or sun effects may exacerbate these changes.There is still a need for active ingredients or active ingredient combinations for hair treatment products with good nourishing properties, which also strengthen the adhesion of dyes to the hair fibers and thus preserve the authenticity of the artificially produced hair color, and further develop hair treatment products in this regard.
  • the present application was therefore based on the object to provide good skin-friendly and nourishing hair treatment compositions which have excellent foam properties and have a good rinsability with water and also reduce or prevent the washing out of color from dyed hair.
  • the nourishing hair treatment products should have a constant conditioning performance regardless of the water quality and in particular fine hair and / or damaged hair and thereby strengthen the hair in their structure and so protect against splits and breakage and improve combability and grip. In addition, they should have a germ-reducing effect.
  • a first object of the present invention are hair treatment compositions containing by weight
  • R ' is a straight-chain or branched, saturated or unsaturated hydrocarbon radical having 1 to 24 carbon atoms
  • R is a protein, a peptide or a protein hydrolyzate means
  • X is -C (O) O- or -N + (R '" 2 ) -R' V - or -N (R"')R' V - or -C (O) -N (R V ) R VI - stands,
  • Hair treatment compositions for the purposes of the present invention are, for example, hair shampoos, hair conditioners, conditioning shampoos, hairsprays, hair conditioners, hair conditioners, hair wraps, hair tonics, perming solutions, hair dye shampoos, hair dyes, hair fixatives, hair dressings, hairstyling preparations, hair lotions, mousses, hair gels , Hair waxes or their combinations.
  • Preferred agents are therefore shampoos, conditioners or hair tonics.
  • the hair treatment compositions contain as the first essential ingredient 0.001 to 20 wt .-% of at least one alpha-substituted aldehyde.
  • Preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.01 to 10% by weight, preferably from 0.05 to 7.5% by weight, more preferably from 0.1 to 6% by weight and in particular from 0.15 to 5% by weight of alpha-substituted aldehyde (s) of the formula (I)
  • Aldehydes preferably to be used according to the invention are described by the numbers 1 to 176 on pages 3 to 6 of the priority document.
  • Very particularly preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.01 to 10% by weight, preferably from 0.05 to 7.5% by weight, more preferably from 0 to 1 to 6% by weight. % and in particular 0, 15 to 5 wt .-% of at least one alpha-substituted aldehyde from the group
  • Hair treatment compositions containing these aldehydes have excellent care properties on both thin and normal hair, provide a significant structural reinforcement and prevent the washing and bleeding of chemically colored hair very effectively.
  • compositions according to the invention contain from 0.001 to 20% by weight of at least one proteolipid of the formula (I)
  • R ' is a straight-chain or branched, saturated or unsaturated hydrocarbon radical having 1 to 24 carbon atoms
  • R is a protein, a peptide or a protein hydrolyzate means
  • X is -C (O) O- or -N + (R "' 2 ) -R' V - or -N (R"')R' V - or -C (O) -N (R V ) R VI - stands,
  • Preferred cosmetic agents contain - by weight - 0, 01 to 10 wt .-%, preferably 0.02 to 5 wt .-%, particularly preferably 0.05 to 2.5 wt .-%, more preferably 0, 1 to 1 wt .-% and in particular 0, 15 bis 0.5% by weight of proteolipid (s).
  • R " in formula (I) represents a peptide or a protein or a protein hydrolyzate
  • Preferred radicals R " are oligopeptides which have at least one amino acid sequence Glu-Glu-Glu, where the amino group may be free or protonated and the carboxy groups may be free or deprotonated.
  • the parenthetized hydrogen atom of the amino group, as well as the parenthetical group of the acid function means that the groups concerned may be present as such (then an oligopeptide having the relevant number of amino acids as shown) Formula are three amino acids) or that the amino acid sequence is present in an oligopeptide, which includes even more amino acids - depending on where the other (s) amino acid (s) is / are bound, the parenthetical components of the above Formula replaced by the other amino acid residue (s).
  • Oligopeptides in the sense of the present application are acid amide-like linked by peptide bonds condensation products of amino acids comprising at least 3 and a maximum of 25 amino acids.
  • the molecular weight of the proteolipid contained in the agents can vary , Preferred cosmetic agents are characterized in that the proteolipid has a molecular weight of from 1000 to 30,000 Da, preferably from 1250 to 25,000 Da, more preferably from 1,500 to 20,000 Da and in particular from 2,000 to 15,000 Da.
  • oligopeptides are preferably used, which not only consist of the three glutamic acids, but contain further bound to this sequence amino acids. These additional amino acids are preferably selected from certain amino acids, while certain other agents are less preferred.
  • radical R " contains the proteolipids used in the agents tyrosine It is further preferred if the radical R " contains the proteolipids used in the agents leucine.
  • radical R " contains the proteolipids used in the agents isoleucine. It is further preferred if the radical R " contains the proteolipids used in the agents arginine.
  • radical R " contains the proteolipids used in the agents valine.As the radical R " in particularly preferred oligopeptides or in the preferred oligopeptides amino acid sequences are described below:
  • a particularly preferred oligopeptide additionally contains tyrosine, which is preferably linked via its acid function to the Glu-Glu-Glu sequence.
  • Preferred cosmetic agents are therefore characterized in that the oligopeptide contained in the proteolipids of the formula (I) as the radical R "has at least one amino acid sequence Tyr-Glu-Glu-Glu, where the amino group is free or protonated and the carboxy groups are free
  • Another particularly preferred oligopeptide additionally contains isoleucine, which is preferably linked to the Glu-Glu-Glu sequence via its amino function, and therefore preferred cosmetic agents are characterized in that in the proteolipids of the formula (I) as Residual R " contained oligopeptide having at least one amino acid sequence Glu-Glu-Glu-Ile, wherein the amino group is free or protonated and the carboxy groups may be free or deprotonated.
  • Oligopeptides having both of the aforementioned amino acids are preferred.
  • Cosmetic agents are particularly preferred in which the oligopeptide contained in the proteolipids of the formula (I) as the radical R "has at least one amino acid sequence Tyr-Glu-Glu-Ile, where the amino group is free or protonated and the carboxy- Groups may be free or deprotonated.
  • oligopeptides additionally contain arginine, which is preferably bound to isoleucine.
  • Preferred cosmetic compositions are therefore characterized in that in the proteolipids of formula (I) having oligopeptide contained as the radical R "represents at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg, wherein said amino groups free or protonated and Carboxy groups may be present freely or deprotonated.
  • Still further preferred oligopeptides additionally contain valine, which is preferably bound to the arginine.
  • Further preferred cosmetic agents are therefore characterized in that the oligopeptide contained in the proteolipids of the formula (I) as the radical R "has at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val, where the amino groups are free or protonated and the carboxy groups may be present freely or deprotonated.
  • Still further preferred oligopeptides additionally contain leucine, which is preferably bound to valine.
  • Further preferred cosmetic agents are characterized in that the oligopeptide contained in the proteolipids of the formula (I) as the radical R "has at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, the amino groups being free or protonated and the carboxy groups may be free or deprotonated.
  • Particularly preferred oligopeptides additionally contain leucine, which is preferably bound to the tyrosine.
  • Further preferred cosmetic agents are characterized in that the oligopeptide contained in the proteolipids of the formula (I) as the radical R "has at least one amino acid sequence Leu-Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, where the amino- Groups free or protonated and the carboxy groups may be free or deprotonated.
  • especially cosmetic agents which contain at least one proteolipid of the formula (I) in which R "has at least one amino acid sequence Leu-Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, the amino groups being free or protonated and the carboxy groups may be free or deprotonated.
  • the radical R " in formula (I) may be a peptide or a protein or a protein hydrolyzate, with protein hydrolysates being preferred Protein hydrolysates are product mixtures obtained by acid, base or enzymatically catalyzed degradation of proteins (proteins) Protein hydrolysates of both vegetable and animal origin can be used.
  • Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein protein hydrolysates, which may also be present in the form of salts.
  • Such products are, for example, under the trademarks Dehylan ® (BASF SE), Promois® ® (Interorgana) Collapuron ® (BASF SE), Nutrilan® ® (BASF SE), Gelita-Sol ® (German Gelatinefabriken Stoess & Co), Lexein ® ( Inolex) and kerasol tm ® Croda) (marketed.
  • Protein hydrolysates of plant origin for example soybean, almond, rice, pea, potato and wheat protein hydrolysates.
  • Such products are, for example, under the trademarks Gluadin ® (BASF SE), diamine ® (Diamalt) ® (Inolex) and Crotein ® (Croda) available.
  • the radical R " is selected from keratin or keratin hydrolysates
  • Preferred cosmetic agents are characterized in that they contain at least one proteolipid of formula (I) in which R " is for keratin or a Keratinhydrolysat stands.
  • particularly preferred cosmetic agents are characterized in that they contain at least one proteolipid of the formula (I) in which X represents -N + (CH 3 ) 2-CH 2 -CH (OH) -CH 2 - and R 'represents - ( CH 2 ) i 7-CH 3 .
  • particularly preferred cosmetic agents are characterized in that they contain at least one proteolipid of the formula (I) in which X represents -N + (CH 3) 2 -CH 2 -CH (OH) -CH 2 - and R 'represents - (CH 2 i i-23-CH 3 .
  • Further preferred cosmetic agents are characterized in that they contain at least one proteolipid of the formula (I) in which X is -C (O) -O- and R 'is - (Chh-Cha.
  • the agents preferably contain the proteolipid (s) in an amount of from 0.01 to 10.0% by weight and more preferably from 0.05 to 2.0% by weight, based in each case on the weight of the ready-to-use agent ,
  • preferred hair treatment compositions according to the invention are characterized in that they contain -0.01 to 15 wt .-%, preferably 0.05 to 10 wt .-%, more preferably 0, 1 to 7.5 wt .-% by weight.
  • compositions according to the invention are characterized in that they contain - based on their weight -0, 01 to 15 wt .-%, preferably 0.05 to 10 wt .-%, more preferably 0, 1 to 7.5 wt .-% and in particular 0.15 to 5 wt .-% of at least one proteolipid of the formula (II in which X is -C (O) -O- or -N + (CH 3 ) 2 -CH 2 -CH (OH) -CH 2 - and R 'is - (CH 2 ) n -23-CH 3 , in particular represents - (CH 2 ) i7-CH 3 .
  • agents according to the invention may contain amino-functional silicones to further increase the conditioning effects.
  • Preferred agents according to the invention contain from 0.001 to 50% by weight of at least one amino-functional silicone.
  • Particularly preferred agents according to the invention are characterized in that they contain at least one amino-functional silicone of the formula (Si-IIa)
  • n and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of 0 to 1999 and in particular of 49 to 149 and m preferably values of 1 to 2000 , in particular from 1 to 10 assumes.
  • compositions according to the invention which are an amino-functional silicone of the formula (Si-IIb)
  • R is -OH, -O-CH3 or a -CH3 group and m
  • n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2000, preferably between 50 and 150, wherein the sum (n1 + n2) preferably assumes values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10.
  • silicones are referred to as amodimethicones according to the INCI declaration.
  • agents according to the invention which contain an amino-functional silicone whose amine number is above 0.25 meq / g, preferably above 0.3 meq / g and in particular above 0.4 meq / g, are preferred ,
  • the Amine number stands for the milliequivalents of amine per gram of the amino-functional silicone. It can be determined by titration and also expressed in mg KOH / g.
  • Hair-treatment agents preferred according to the invention are characterized in that, based on their weight, they contain from 0.01 to 20% by weight, preferably from 0.05 to 10% by weight, more preferably from 0.1 to 7.5% by weight and in particular from 0.15 to 5% by weight of amino-functional silicone (s).
  • the agents according to the invention contain amino-functional silicone (s) with terminal (r / n) hydroxy group (s).
  • pretreatment agents which contain at least one silicone of the formula (Si-V) have proven particularly effective with regard to the desired effects:
  • A represents a group -OH, -0-Si (CH 3) 3, -0-Si (CH3) 20H, -0-Si (CH 3) 20ch 3, D is a group of -H, -Si (CH 3 ) 3 , -Si (CH 3 ) 2 OH, -Si (CH 3 ) 2 OCH 3 ,
  • n and c are integers between 0 and 1000,
  • Hair treatment compositions according to the invention which - based on their weight - 0.01 to 20 wt.%, Preferably 0.01 to 20 wt .-%, preferably 0, 1 to 10 wt .-%, more preferably 0.5 to 7.5 Wt .-% and in particular 0.1 to 5 wt .-% of at least one silicone of the formula (Si-V) contain:
  • A is a group -OH, -O-Si (CH 3 ) 3 , -O-Si (CH 3 ) 2 OH, -O-Si (CH 3 ) 2 OCH 3
  • D is a group -H, -Si (CH 3 ) 3, -Si (CH 3 ) 20H, -Si (CH 3 ) 2 OCH 3
  • b, n and c are integers between 0 and 1000
  • the individual siloxane units having the indices b, c and n are randomly distributed, i. it does not necessarily have to be block copolymers.
  • compositions according to the invention which, based on their weight, 0.001 to 20 wt.%, Preferably 0.01 to 10 wt.%, Particularly preferably 0.05 to 7.5 wt.% And in particular 0.5 to 5 wt.% Of at least one 4-morpholinomethyl-substituted silicone containing structural units of the formulas (Si-Via), (Si-Vlb) and (Si-Vlc)
  • R 1 is -CH 3 , -OH, -OCH 3 , -O-CH 2 CH 3 , -O-CH 2 CH 2 CH 3 , or -O-CH (CH 3 ) 2 ;
  • R 2 is -CH 3 , -OH, or -OCH 3 ,
  • Particularly preferred hair treatment compositions according to the invention contain, based on their weight, from 0.001 to 20% by weight, preferably from 0.01 to 10% by weight, particularly preferably from 0.05 to 7.5% by weight and in particular from 0.5 to 5% by weight.
  • R 1 is -CH 3 , -OH, -OCH 3 , -O-CH 2 CH 3 , -O-CH 2 CH 2 CH 3 , or -O-CH (CH 3 ) 2 ;
  • R2 is -CH 3 , -OH, or -OCH 3 .
  • B represents a group -OH, -0-Si (CH 3) 3, -0-Si (CH3) 20H, -0-Si (CH 3) 20ch 3;
  • D is a group -H, -Si (CH 3 ) 3, -Si (CH 3 ) 20H, -Si (CH 3 ) 2 OCH 3 ,
  • a, b and c independently represent integers between 0 and 1000, with the proviso that a + b + c> 0
  • the units a, b, c, m and n are distributed randomly or in blocks in the molecule.
  • Structural formula (Si-VI) is intended to illustrate that the siloxane groups n and m do not necessarily have to be bound directly to an end grouping B or D, respectively. Rather, in preferred formulas (Si-VI) a> 0 or b> 0 and in particularly preferred formulas (Si-Vl) a> 0 and c> 0, i. the terminal moiety B or D is preferably attached to a dimethylsiloxy moiety. Also in formula (Si-Vl), the siloxane units a, b, c, m and n are preferably randomly distributed.
  • the agents of the invention preferably contain the silicone (s) in the form of an emulsion, more preferably in the form of a microemulsion ,
  • Nonionic components which are particularly suitable here are ethoxylates of decanol, undecanol, dodecanol, tridecanol, etc. Ethoxylated tridecanols have proven to be particularly suitable, which are incorporated with particular preference into the compositions according to the invention.
  • compositions which are particularly preferred according to the invention are characterized in that they contain 0.00001 to 5% by weight, preferably 0.0001 to 3.5% by weight, particularly preferably 0.001 to 2% by weight, based on their weight preferably 0.01 to 1 wt .-% and in particular 0.1 to 0.5 wt .-% branched, ethoxylated tridecanol (INCI name: Trideceth-5) or o iso-tridecyl-u hydroxypolyglycolether (INCI name: Trideceth -10) or mixtures thereof.
  • compositions of the invention may contain other silicone (s) which are not amino functional.
  • preferred hair treatment compositions are characterized in that they - based on their weight - 0.01 to 20 wt .-%, preferably 0, 1 to 10 wt .-%, more preferably 0.5 to 7.5 wt .-% and in particular 1 to 5 wt .-% non-amino-functional silicone (s) included. Preferred silicones are described below.
  • x is a number from 0 to 100, preferably from 0 to 50, more preferably from 0 to 20 and in particular 0 to 10.
  • silicones are called DIMETHICONE according to the INCI nomenclature.
  • the following compounds are preferably used as the silicone of the formula Si-I: (CH 3 ) 3 Si-O-Si (CH 3 ) 3 (CH 3 ) 3 Si-O- (CH 3 ) 2 Si-O- Si (CH 3 ) 3 (CH 3 ) 3 Si [O- (CH 3 ) 2 Si] 2 -O-Si (CH 3 ) 3 (CH 3 ) 3 Si [O- (CH 3 ) 2 Si] 3 -0-Si (CH 3 ) 3 (CH 3 ) 3 Si - [0- (CH 3 ) 2 Si] 4 -O-Si (CH 3 ) 3
  • (CH 3 ) 3 Si [0- (CH 3 ) 2 Si] is-0-Si (CH 3 ) 3 (CH 3 ) 3 Si [0- (CH 3 ) 2 Si] i 6 -O-Si (CH 3 ) 3 (CH3) 3 Si- [0- (CH 3) 2 Si] i7-0-Si (CH 3) 3 (CH 3) 3 Si- [0- (CH3) 2 Si] i8-0-Si (CH 3) 3
  • the hair treatment compositions of the invention may contain surfactant (s).
  • surfactant in cleaning compositions (shampoos), in particular anionic surfactants have proven useful, in conditioning compositions, cationic surfactants are often used ingredients; Due to their advantageous properties, amphoteric surfactants are used with particular advantage both in shampoos and in conditioners.
  • the hair treatment compositions of the invention may contain at least one anionic surfactant.
  • Suitable anionic surfactants and emulsifiers for the compositions according to the invention are all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. As a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group having about 8 to 30 carbon atoms. In addition, glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups may be present in the molecule.
  • Preferred hair treatment compositions contain - based on their weight - 0.5 to 20 wt .-%, preferably 0.75 to 15 wt .-%, more preferably 1 to 12 wt .-% and in particular 2 to 10 wt .-% of anionic ( s) surfactant (s).
  • Particularly preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.5 to 20% by weight, preferably from 0.75 to 15% by weight, more preferably from 1 to 12% by weight and in particular from 2 to 10 wt .-% alkyl (ether) sulfate of the general formula R- (OCH 2 -CH 2 ) n -OS0 3 X, in which R is a straight-chain or branched, saturated or unsaturated alkyl group having 8 to 24 carbon atoms, n the Number 0 or 1 to 12, and X represents an alkali, alkaline earth, ammonium or alkanolamine ion included.
  • the hair treatment compositions of the invention may contain at least one amphoteric surfactant and / or at least one nonionic surfactant.
  • Particularly preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.3 to 20% by weight, preferably from 0.5 to 8% by weight, more preferably from 0.75 to 6% by weight and in particular 1 to 5 wt .-% amphoteric surfactant (s) included.
  • amphoteric surfactants or as zwitterionic surfactants called surfactants, which have both a negative and a positively charged functional group.
  • Particularly preferred hair treatment compositions contain as amphoteric surfactants betaines of the formula (Bet-I)
  • R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms.
  • Cocoamidopropylbetaine Representatives derived from coconut fatty acids, are preferred and are referred to as Cocoamidopropylbetaine. According to the invention, particular preference is given to using surfactants of the formula (Bet-I) which are a mixture of the following representatives:
  • hair-treatment compositions according to the invention are preferred which - based on their weight - 0.25 to 8 wt .-%, more preferably 0.5 to 7 wt .-%, more preferably 0.75 to 6.5 wt .-% and in particular 1 to 5.5 wt .-% of surfactant (s) of the formula (Bet-I) included.
  • the hair-treatment compositions of the invention may be used with particular preference as amphoteric surfactants betaines of the formula (Bet-II)
  • R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms.
  • surfactants are referred to according to the INCI nomenclature as amphoacetates, wherein the representatives derived from coconut fatty acids are preferred and are referred to as cocoamphoactetates.
  • surfactants of this type also always contain betaines of the formula (Bet-I 1a)
  • R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms and M is a cation.
  • surfactants are referred to according to the INCI nomenclature as Amphodiacetate, wherein the representatives derived from coconut fatty acids are preferred and are referred to as Cocoamphodiactetate.
  • hair-treatment compositions according to the invention which - based on their weight - 0.25 to 8 wt .-%, more preferably 0.5 to 7 wt .-%, more preferably 0.75 to 6.5 wt .-% and in particular 1 to 5.5 wt .-% of surfactant (s) of the formula (Bet-II) included.
  • cosmetic agents according to the invention are preferred in which the radical R in the formulas (Bet-I) and (Bet-II) is selected from
  • the hair treatment agents may contain nonionic surfactant (s).
  • Hair treatment agents preferred according to the invention contain, based on their weight, 0.3 to 10% by weight, preferably 0.5 to 8% by weight, more preferably 0.75 to 6% by weight and in particular 1 to 5% by weight. % nonionic surfactant (s).
  • the hair treatment agents may contain cationic surfactant (s).
  • Cationic surfactants of the quaternary ammonium compound type, the esterquats and the amidoamines can be used according to the invention.
  • Preferred quaternary ammonium compounds are ammonium halides, in particular chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides.
  • the long alkyl chains of these surfactants preferably have 10 to 18 carbon atoms, such as.
  • cetyltrimethylammonium chloride stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylammonium chloride, Lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride.
  • Further preferred cationic surfactants are the imidazolium compounds known under the INCI names Quaternium-27 and Quaternium-83.
  • Particularly preferred hair treatment compositions according to the invention are characterized in that they contain as cationic care substance - based on their weight - 0.05 to 7.5 wt .-%, preferably 0.1 to 5 wt .-%, particularly preferably 0.2 to 3, 5 wt .-% and in particular 0.25 to 2.5 wt .-% cationic (s) surfactant (s) from the group of quaternary ammonium compounds and / or esterquats and / or amidoamines.
  • cationic care substance - based on their weight - 0.05 to 7.5 wt .-%, preferably 0.1 to 5 wt .-%, particularly preferably 0.2 to 3, 5 wt .-% and in particular 0.25 to 2.5 wt .-% cationic (s) surfactant (s) from the group of quaternary ammonium compounds and / or esterquats and / or amidoamines.
  • Particularly preferred hair treatment compositions according to the invention are characterized in that, based on the weight of the composition, sis contains -0.05 to 20% by weight, preferably 0 to 1 to 10% by weight, more preferably 0.25 to 8% by weight. and in particular from 0.5 to 7% by weight of cationic surfactant (s), preferably from 0.05 to 20% by weight, preferably from 0.1 to 10% by weight, more preferably from 0.25 to 8% by weight .-% and in particular 0.5 to 7 wt .-% behenyl trimethyl ammonium chloride.
  • cationic surfactant preferably from 0.05 to 20% by weight, preferably from 0.1 to 10% by weight, more preferably from 0.25 to 8% by weight .-% and in particular 0.5 to 7 wt .-% behenyl trimethyl ammonium chloride.
  • compositions of the invention may contain at least one cationic polymer.
  • Cationic polymers increase the care performance of the hair treatment compositions according to the invention (in particular the effectiveness of the hair breakage compositions according to the invention).
  • preferred hair treatment agents contain, based on the weight of the composition, 0.01 to 3% by weight, preferably 0.05 to 2% by weight, further preferably 0.1 to 1.5% by weight and in particular 0.15 to 0.8% by weight of cationic polymer (s).
  • Cationic polysaccharide polymers are used with particular preference according to the invention as cationic polymers.
  • Cationic polysaccharide polymers increase the care performance of the hair treatment compositions according to the invention (in particular the effectiveness of the hair breakage compositions according to the invention).
  • Suitable cationic polysaccharide polymers may be selected from cationic cellulose compounds and / or from cationic guar derivatives.
  • Particularly preferred hair treatment compositions according to the invention contain as cationic polysaccharide polymer (s) - based on the weight of the composition - 0.01 to 3 wt .-%, preferably 0.05 to 2 wt .-%, more preferably 0.1 to 1, 5 wt .-% and in particular 0.15 to 0.8 wt .-% of at least one polymer from the group of cationic cellulose polymers and / or cationic guar derivatives.
  • s cationic polysaccharide polymer
  • Cationic cellulose compounds in the sense of the invention are those which carry more than one permanent cationic charge in at least one side chain.
  • Cellulose is composed of beta-1, 4-glycosidically linked D-glucopyranose units and forms unbranched, water-insoluble chains.
  • side chain of a cellulose chemical substituents are defined which bind to the cellulose skeleton and do not belong to the native cellulose since they have been subsequently introduced, for example, by chemical synthesis. Preference is given to quaternized cellulose polymers derived from hydroxy (C 2 -C 4) -alkylcelluloses, more preferably from hydroxyethylcelluloses.
  • Such polymers are known to those skilled in the art and commercially available from various companies. Particularly preferred are the cationic cellulose derivatives known under the INCI names Polyquaternium-4, Polyquaternium-10, Polyquaternium-24, Polyquaternium-67 and / or Polyquaternium-72. Very particular preference is given to polyquaternium-10, polyquaternium-24 and / or polyquaternium-67 and particular preference to polyquaternium-10.
  • Preferred hair treatment compositions according to the invention contain as cationic polysaccharide polymer (s) - based on the weight of the composition - 0.01 to 3 wt .-%, preferably 0.05 to 2 wt .-%, more preferably 0.1 to 1, 5 wt .-% and in particular 0, 15 to 0.8 wt .-% of at least one polymer from the group of Polyquaternium-4, Polyquaternium-10, Polyquaternium-24, Polyquaternium-67 and / or Polyquaternium-72.
  • s cationic polysaccharide polymer
  • Particularly preferred hair treatment compositions according to the invention contain as cationic polysaccharide polymer (s) - based on the weight of the composition - 0.01 to 3 wt .-%, preferably 0.05 to 2 wt .-%, more preferably 0.1 to 1, 5 wt .-% and in particular 0.15 to 0.8 wt .-% Polyquaternium-10.
  • Suitable cationic guar derivatives in the context of the invention are cationic hydroxyalkyl guar derivatives, preferably cationic hydroxyethyltrimethylammonium guar and / or cationic hydroxypropyltrimethylammonium guar with average molecular weights between 100,000 and 2,000,000 daltons. Particularly preferred are the cationic guar polymers having a molecular weight (weight average) between 200,000 and 1,600,000 daltons known by the INCI name Guar Hydroxypropyltrimonium Chloride.
  • the cationic charge density of these guar polymers is preferably at least 0.4 meq / g, preferably at least 0.5 meq / g and especially at least 0.6 meq / g.
  • Their nitrogen content is preferably in the range of 1, 1 to 1, 8 wt .-% (based on their total weight).
  • Cationic guar derivatives which are known under the INCI designation Guar Hydroxypropyltrimonium Chloride, are known in the art and available, for example under the trade name Cosmedia Guar ®, N-Hance ® and / or Jaguar ® from different vendors.
  • Particularly preferred hair treatment compositions according to the invention contain as cationic polysaccharide polymer (s) - based on the weight of the composition - 0.01 to 3 wt .-%, preferably 0.05 to 2 wt .-%, more preferably 0, 1 to 1, 5 wt .-% and in particular 0, 15 to 0.8 wt .-% guar hydroxypropyltrimonium chlorides.
  • preferred hair treatment compositions are characterized in that they - based on the weight of the composition - 0.01 to 3 wt .-%, preferably 0.05 to 2 wt .-%, further preferably 0.1 to 1, 5 wt. % and in particular 0.15 to 0.8% by weight of cationic polymer (s), preferably 0.01 to 3% by weight, preferably 0.05 to 2% by weight, more preferably 0, 1 to 1, 5 wt .-% and in particular 0, 15 to 0.8 wt .-% of at least one polymer from the group of cationic cellulose polymers and / or cationic guar derivatives.
  • succinimidyl esters can further enhance the effect of the agents according to the invention.
  • significant increases in performance are observed.
  • Hair treatment compositions which are preferred according to the invention are therefore characterized in that they contain, based on the weight of the composition, additionally from 0.001 to 10% by weight of at least one succinimidyl ester.
  • Succinimidyl esters are esters of carboxylic acids with (optionally substituted) / V-hydroxysuccinimide (NHS, IUPAC 1-hydroxy-2,5-pyrrolidinedione) and are also referred to as NHS esters.
  • Hair treatment compositions which are preferred according to the invention are characterized in that they additionally contain from 0.01 to 10% by weight, preferably from 0.05 to 7.5% by weight, more preferably from 0.1 to 6% by weight, based on the weight of the composition. % and in particular 0.15 to 5% by weight of (one) succinimidyl ester (s) of the formula (III)
  • R1 represents -H or an ionic group.
  • R is an optionally substituted saturated or unsaturated, linear, branched or cyclic, aliphatic or aromatic hydrocarbon radical having at least 5 C atoms.
  • Suitable ionic groups R1 include both anionic groups such as phosphate, phosphonate, phosphinate, sulfate, sulfonate, sulfinate, sulfenate, oxysulfonate, carboxylate groups and cationic groups such as substituted or unsubstituted ammonium groups. Zwitterionic / betainic groups such as carboxybetaine or sulfobetaine groups are also possible.
  • R 1 is -H or -OSO 3 " or -SO 3 " or -SO 2 - or -COO " or -NH 3 + or -N (CH 3 ) H 2 + or -N (CH 3 ) 2 H + or -N (CH 3 ) 3 + or -N + (CH 3 ) 2 (CH 2 ) 2-COO- or -N + (CH 3 ) 2 (CH 2 ) 3 -SO 3 -.
  • succinimidyl esters to be used according to the invention are described in the priority document on pages 39 to 41 with the numbers 1 to 72.
  • Very particularly preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.01 to 10% by weight, preferably from 0.05 to 7.5% by weight, more preferably from 0 to 1 to 6% by weight. % and in particular 0, 15 to 5 wt .-% of at least one Succinimidylesters from the group
  • X is H, a monovalent cation or the nth part of an n-valent cation
  • Complexing agents can increase the effect of the agents according to the invention even further, in particular complexing agents which are derived from polycarboxylic acids have proved useful.
  • Hair treatment compositions which are preferred according to the invention are therefore characterized in that they contain, based on their weight, from 0.001 to 20% by weight of complexing agents from the group consisting of tetrasodium A / A / bis (carboxylatomethyl) -L-glutamate (Tetrasodium glutamate diacetate, GLDA).
  • complexing agents from the group consisting of tetrasodium A / A / bis (carboxylatomethyl) -L-glutamate (Tetrasodium glutamate diacetate, GLDA).
  • Pentasodium diethylenetriaminepentaacetate DTPA
  • tetrasodiumiminodisuccinate IDS
  • EDTA tetrasodium Ethylenediaminetetraacetate
  • EDDS tetrasodium ethylenediamine disuccinic acid
  • HEDTA trisodium hydroxyethylethylenediaminetriacetic acid
  • Extremely preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.001 to 20% by weight, preferably from 0.005 to 15% by weight, preferably from 0.01 to 10% by weight, more preferably from 0.05 to 7.5 wt .-% and in particular 0, 1 to 5 wt .-% complexing agent from the group
  • the agents according to the invention may contain only one of the three complexing agents mentioned. But it is also possible that the means according to the invention two or all three of the above. Complexing agents, the manganese of all the complexing agents contained in the agents from the o.g. Group within the quantitative range 0.01 to 20 wt .-% is.
  • Hair treatment compositions which are preferred according to the invention are characterized in that they contain, based on their weight, from 0.005 to 15% by weight, preferably from 0.01 to 10% by weight, more preferably from 0.05 to 7.5% by weight and in particular from 0 , 1 to 5 wt .-% tetrasodium A /, A / -bis (carboxylatomethyl) - L-glutamate (Tetrasodium Glutamate Diacetate, GLDA) included.
  • Hair treatment compositions which are likewise preferred according to the invention are characterized in that they contain 0.005 to 15% by weight, preferably 0.01 to 10% by weight, based on their weight preferably 0.05 to 7.5 wt .-% and in particular 0, 1 to 5 wt .-% pentasodium Diethylenetriaminepentaacetate (DTPA) included.
  • DTPA pentasodium Diethylenetriaminepentaacetate
  • Hair treatment compositions which are likewise preferred according to the invention are characterized in that they contain, based on their weight, from 0.005 to 15% by weight, preferably from 0.01 to 10% by weight, more preferably from 0.05 to 7.5% by weight and in particular 0, 1 to 5 wt .-% Tetranatnumiminodisucciniat (IDS) included.
  • IDDS Tetranatnumiminodisucciniat
  • DTPA pentasodium diethylenetriaminepentaacetate
  • tetranatoiminiminodisuccinate From 0.01 to 10% by weight, more preferably from 0.05 to 7.5% by weight and in particular from 0.1 to 5% by weight of tetrasodium A /, A / -bis (carboxylatomethyl) -L- glutamate (Tetrasodium Glutamate Diacetate, GLDA) and 0.01 to 10% by weight, more preferably 0.05 to 7.5% by weight, and most preferably 0.1 to 5% by weight, of tetranatoiminiminodisuccinate (IDS).
  • IDDS tetranatoiminiminodisuccinate
  • DTPA pentasodium diethylenetriamine pentaacetate
  • IDS tetranatoiminiminodisuccinate
  • preferred hair treatment compositions contain - based on their weight -0, 1 to 5 wt .-% tetrasodium A /, A / -bis (carboxylatomethyl) -L-glutamate (Tetrasodium glutamate diacetates, GLDA) and 0, 1 to 5 wt % Pentasodium diethylenetriamine pentaacetate (DTPA) and 0.1 to 5 weight percent tetranatoiminiminodisuccinate (IDS).
  • DTPA Pentasodium diethylenetriamine pentaacetate
  • IDDS tetranatoiminiminodisuccinate
  • the hair treatment compositions may contain at least one divalent or trivalent metal salt. These lead to an improved washout prevention. To achieve an optimum effect, it is advantageous if the metal salts are present in dissolved form in the compositions according to the invention.
  • the hair cleansing and care compositions according to the invention therefore contain water-soluble divalent or trivalent metal salts.
  • water-soluble is understood to mean that at 20 ° C. at least 1 g of the respective salt can be completely dissolved in 1 l of water.
  • Suitable divalent or trivalent metal salts may be selected from divalent or trivalent organic and / or inorganic salts.
  • Particularly suitable cations within these salts may preferably be selected from alkaline earth metal cations and from copper, zinc, iron (II), iron (III) and / or aluminum cations. Very particularly preferred are alkaline earth metal cations and particularly preferably calcium and magnesium cations.
  • Particularly suitable organic anions within these salts may preferably be selected from formate, acetate, lactate, succinate, citrate, tartrate, malate, maleate, Oxalate and / or glycolate ions. Very particular preference is given to acetate, lactate and / or citrate salts with the abovementioned cations.
  • Particularly preferred organic salts are calcium, calcium, calcium, magnesium, magnesium and / or magnesium acetate.
  • Particularly suitable inorganic anions within these salts can be selected from halide, sulfate, phosphate and / or carbonate ions. Very particular preference is given to sulfate and / or halide ions, such as chloride and bromide ions.
  • Particularly preferred inorganic salts are calcium chloride, calcium sulfate, magnesium chloride and / or magnesium sulfate.
  • the proportion by weight of the at least one divalent or trivalent metal salt in the total weight of the hair treatment compositions according to the invention is preferably from 0.01 to 10% by weight, preferably from 0.1 to 7.5% by weight, more preferably from 0.2 to 5% by weight. % and in particular 0.3 to 3 wt .-%.
  • preferred hair treatment compositions contain - based on their weight - 0.01 to 10 wt .-%, preferably 0.1 to 7.5 wt .-%, more preferably 0.2 to 5 wt .-% and in particular 0.3 to 3 wt .-% of at least one divalent or trivalent metal salt from the group of organic or inorganic copper, zinc, iron (II), calcium, magnesium, iron (III) and / or aluminum salts.
  • the water-soluble salts are particularly preferred. Most particularly preferred within this embodiment are calcium lactate, calcium citrate, calcium acetate, magnesium lactate, magnesium citrate, magnesium acetate, calcium halides, calcium hydroxide, magnesium halides and / or magnesium hydroxide.
  • the hair treatment compositions preferably contain the active ingredients described above in a cosmetically acceptable carrier.
  • a cosmetically acceptable carrier for the purposes of the invention, this is preferably understood as meaning an aqueous or aqueous-alcoholic carrier.
  • the cosmetic carrier preferably contains at least 50% by weight, more preferably at least 60% by weight, particularly preferably at least 70% by weight and especially preferably at least 75% by weight of water.
  • the cosmetic carrier may contain 0.01 to 40 wt .-%, preferably 0.05 to 30 wt .-% and in particular 0, 1 to 20 wt .-% of at least one alcohol.
  • Suitable alcohols are, for example, ethanol, ethyl diglycol, 1-propanol, 2-propanol, isopropanol, 1,2-propylene glycol, glycerol, diglycerol, triglycerol, 1-butanol, 2-butanol, 1, 2-butanediol, 1, 3-butanediol, 1-pentanol, 2-pentanol, 1, 2-pentanediol, 1, 5-pentanediol, 1, hexanol, 2-hexanol, 1, 2-hexanediol, 1, 6-hexanediol, polyethylene glycols, sorbitol, sorbitan, benzyl alcohol or mixtures thereof alcohols.
  • compositions according to the invention For a very good (head) skin compatibility of the hair treatment compositions according to the invention, it is advantageous if they have a slightly acidic pH. It has been found that the compositions according to the invention in a pH range from 4.2 to 5.8 have a particularly good skin tolerance and mildness.
  • the hair treatment compositions of the invention preferably have a pH in the range of from 4.2 to 5.8, more preferably from 4.3 to 5.6, most preferably from 4.4 to 5.5, most preferably from 4.5 to 5.4, and more preferably from 4.7 to 5.3.
  • the hair treatment compositions according to the invention may contain vegetable oils, vegetable butters and / or vegetable waxes. These vegetable oil components give the hair improved combability and manageability and increase hair shine.
  • the proportion by weight of the at least one vegetable oil, the vegetable butter and / or the vegetable wax in the total weight of the hair treatment compositions according to the invention is preferably 0.02 to 2.50 wt .-%, more preferably from 0.03 to 2.00 wt .-% , Particularly preferably 0.04 to 1, 50 wt .-% and in particular 0.05 to 1, 00 wt .-%.
  • the hair treatment compositions according to the invention may contain at least one further hair-conditioning active agent, which may be selected from the group of US Pat
  • Suitable protein hydrolysates are product mixtures which can be obtained by acid, alkaline or enzymatically catalyzed degradation of proteins (proteins).
  • Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein hydrolysates, which may also be present in the form of salts.
  • Such products are, for example, under the trademarks Dehylan ® (Cognis), Promois® ® (Interorgana) Collapuron ® (Cognis), Nutrilan® ® (Cognis), Gelita-Sol ® (German Gelatinefabriken Stoess & Co), Lexein ® (Inolex) and kerasol tm ® (Croda) sold.
  • the proportion by weight of the protein hydrolyzate (s) in the total weight of the hair treatment compositions is preferably from 0.01 to 5% by weight, more preferably from 0.025 to 3% by weight and in particular from 0.05 to 2% by weight.
  • Regardless of the source plant, animal, martim, etc. contain protein hydrolysates depending on the degree of hydrolysis of individual amino acids, oligopeptides and possibly polypeptides.
  • the hair treatment compositions according to the invention comprise at least one oligopetide which has at least one amino acid sequence Glu-Glu-Glu, where the amino group can be free or protonated and the carboxy groups can be free or deprotonated.
  • Preferred hair treatment compositions according to the invention are characterized in that based on their weight - 0.0001 to 10 wt .-% of at least one oligopeptide containing at least one amino acid sequence Glu-Glu-Glu, wherein the amino group is free or protonated and the carboxy groups may be free or deprotonated
  • the parenthetized hydrogen atom of the amino group, as well as the parenthetical group of the acid function means that the groups concerned may be present as such (then an oligopeptide having the relevant number of amino acids as shown (see above) Formula 3) or that the amino acid sequence is present in an oligopeptide which comprises further amino acids, depending on where the other amino acid (s) is bound, are the parenthetical components of the above formula by the / the other Replaced amino acid residue (s).
  • compositions of the invention contain, by weight, 0.0001 to 10% by weight of at least one oligopeptide containing at least one amino acid residue Glu-Glu-Glu, i. has at least three consecutive glutamic acids.
  • Oligopeptides in the sense of the present application are acid amide-like linked by peptide bonds condensation products of amino acids comprising at least 3 and a maximum of 25 amino acids
  • the oligopeptide comprises 5 to 15 amino acids, preferably 6 to 13 amino acids, more preferably 7 to 12 amino acids and especially 8, 9 or 10 amino acids.
  • the molecular weight of the oligopeptide contained in the agents of the invention may vary.
  • Preferred hair treatment agents used according to the invention are characterized in that the oligopeptide has a molecular weight of from 650 to 3000 Da, preferably from 750 to 2500 Da, particularly preferably from 850 to 2000 Da and in particular from 1000 to 1600 Da.
  • preferred hair treatment agents are characterized in that the oligopeptide comprises 5 to 15 amino acids, preferably 6 to 13 amino acids, more preferably 7 to 12 amino acids and especially 8, 9 or 10 amino acids and a molecular weight of 650 to 3000 Da, preferably 750 to 2500 Since, more preferably from 850 to 2000 Da and in particular from 1000 to 1600 Da has.
  • oligopeptides which do not consist solely of the three glutamic acids but have further amino acids bound to this sequence.
  • These other amino acids are preferably selected from certain amino acids, while certain other representatives are less preferred in the present invention.
  • oligopeptides used in the agents according to the invention contain no methionine.
  • the oligopeptides used in the agents according to the invention contain no cysteine and / or cystine. It is further preferred if the oligopeptides used in the agents according to the invention contain no aspartic acid and / or asparagine.
  • oligopeptides used in the agents according to the invention contain no serine and / or threonine.
  • oligopeptides used in the agents according to the invention contain tyrosine.
  • oligopeptides used in the agents according to the invention contain leucine.
  • oligopeptides used in the agents according to the invention contain isoleucine.
  • oligopeptides used in the agents according to the invention contain arginine.
  • oligopeptides used in the agents according to the invention contain valine.
  • oligopeptides or amino acid sequences contained in the preferred oligopeptides are described below:
  • a particularly preferred oligopeptide additionally contains tyrosine, which is preferably linked via its acid function to the Glu-Glu-Glu sequence.
  • Hair treatment compositions which are preferred according to the invention are therefore characterized in that the oligopeptide contained in them has at least one amino acid sequence Tyr-Glu-Glu-Glu, where the amino group may be free or protonated and the carboxy groups may be free or deprotonated.
  • Another particularly preferred oligopeptide additionally contains isoleucine, which is preferably linked to the Glu-Glu-Glu sequence via its amino function.
  • Hair treatment agents which are preferred according to the invention are therefore characterized in that the oligopeptide contained in them has at least one amino acid sequence Glu-Glu-Glu-Ile, where the amino group can be free or protonated and the carboxy groups can be free or deprotonated. Oligopeptides which have both the abovementioned amino acids (tyrosine and isoleucine) are preferred according to the invention. Hair treatment compositions according to the invention are particularly preferred in which the oligopeptide present in the hair treatment composition has at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile, where the amino group can be free or protonated and the carboxy groups can be free or deprotonated.
  • oligopeptides additionally contain arginine, which is preferably bound to isoleucine
  • Hair treatment compositions according to the invention in which the oligopeptide contained in the hair treatment agent has at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg, where the amino groups are free or protonated and the carboxy groups are free or deprotonated, are particularly preferred.
  • Still further preferred oligopeptides additionally contain valine, which is preferably bound to the arginine.
  • Further preferred hair treatment agents according to the invention are therefore characterized in that the oligopeptide contained in the hair treatment agent has at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val, wherein the amino groups may be free or protonated and the carboxy groups may be free or deprotonated.
  • Still further preferred oligopeptides additionally contain leucine, which is preferably bound to the valine.
  • Further preferred hair treatment compositions according to the invention are characterized in that the oligopeptide contained in the hair treatment agent has at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups are free or may be present deprotonated.
  • oligopeptides additionally contain leucine, which is preferably bound to the tyrosine.
  • Further preferred hair treatment compositions according to the invention are characterized in that the oligopeptide contained in the hair treatment agent has at least one amino acid sequence Leu-Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups may be free or deprotonated.
  • the proportion by weight of the vitamin (s), vitamin derivative (s), and / or the vitamin precursor (s) in the total weight of the hair treatment agent is preferably from 0.001 to 2% by weight, particularly preferably from 0.005 to 1% by weight and in particular 0, 01 to 0.5 wt .-%.
  • the plant extracts may in the hair treatment compositions according to the invention (based on the total weight of the compositions) preferably in an amount of 0.01 to 10 wt .-%, more preferably from 0.05 to 7.5 wt .-% and in particular from 0, 1 be used to 5 wt .-%.
  • Glycerin may be added to the hair cleansing and care products separately in an amount of up to 10% by weight (based on the total weight of the composition). However, it may also be part of the aforementioned aqueous-alcoholic carrier.
  • hair treatment compositions according to the invention are also suitable for use as antidandruff preparation.
  • the total weight of anti-dandruff agents in the total weight of the hair treatment agent may preferably 0.01 to 10 wt .-%, more preferably 0.025 to 7.5 wt .-%, particularly preferably 0.05 to 5 wt .-% and in particular 0.075 to 3 wt. -%.
  • Suitable antidandruff active ingredients may be selected from piroctone olamine, climbazole, zinc pyrithione, ketoconazole, salicylic acid, sulfur, selenium sulfide, tar preparations, undecenoic acid derivatives, burdock root extracts, poplar extracts, nettle extracts, walnut shell extracts, birch extracts, willow bark extracts, rosemary extracts and / or arnica extracts.
  • the agents according to the invention can be formulated as so-called rinse-off products, ie they are rinsed out of the hair again after a certain exposure time.
  • This exposure time is preferably less than one hour, ie the consumer preferably does not leave the products until the next hair wash in the hair.
  • Another object of the present invention is therefore a method for hair treatment in which an agent according to the invention is applied to dry or damp hair, left there for a period of 10 to 300 seconds and then rinsed out.
  • the agents of the invention may also be formulated as so-called leave-on products, i. are not rinsed out of the hair, but left there until the next hair wash.
  • Another object of the present invention is therefore a method for hair treatment, in which an agent according to the invention is applied to dry or damp hair and left there until the next hair wash.
  • the agents according to the invention lead to a significantly increased strengthening of the inner and outer hair structure.
  • Another object of the present invention is therefore the use of agents according to the invention for strengthening the hair structure, in particular the inner hair structure.
  • Structural strengthening in the sense of the invention is to be understood as meaning a reduction in the damage of keratinic fibers which has arisen due to the most diverse influences.
  • the restoration of natural strength plays an essential role.
  • Restructured fibers are characterized for example by an improved gloss, improved grip and easier combing.
  • they have an optimized strength and elasticity.
  • a successful structure strengthening or restructuring can be physically detected as a melting point increase in comparison to the damaged fiber.
  • compositions of the invention also lead to a significantly increased stability of artificial dyeings against the washing out of paint.
  • chemically dyed hairs can be washed significantly more frequently with the compositions according to the invention, without the undesired bleeding or color fading occurring.
  • Another object of the present invention is therefore the use of agents according to the invention for reducing the washout of color from chemically colored hair.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des agents de traitement capillaire, comprenant, par rapport à leur poids, 0,001 à 20 % en poids d'au moins un aldéhyde alpha-substitué et 0,001 à 20 % en poids d'au moins un protéolipide de formule (II): R'-X-R'', dans laquelle -R' représente un radical hydrocarbure saturé ou insaturé à chaîne linéaire ou ramifié ayant entre 11 et 24 atomes de carbone, -R'' représente une protéine, un peptide ou un hydrolysat de protéine, -X étant -C(O)O- ou -N+(RIII 2)-RIV- ou -N(RIII)RIV- ou -C(O)-N(RV)RV 1-, - RIII étant -(CH2)x-CH3 avec x = 0 - 22 et -RIV étant -CH2-CH(OH)-CH2- ou –(CH2)x- avec x = 0 - 22; - RV et RVI étant indépendamment l'un de l'autre -H ou -(CH2)x-CH3 avec x = 0 - 22; à la condition que R'' représente la kératine ou un hydrolysat de kératine lorsque X est -C(O)O-. Lesdits agents de traitement capillaire permettent d'améliorer le renforcement de l'intérieur de la structure des fibres kératiniques et les effets de soin et de réduire ou d'empêcher le lavage de la couleur de cheveux colorés.
EP17748435.9A 2016-09-30 2017-07-24 Agents de traitement capillaire à effet conditionnant amélioré et résistants au lavage Withdrawn EP3518871A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102016218997.2A DE102016218997A1 (de) 2016-09-30 2016-09-30 Verbessert konditionierende Haarbehandlungsmittel mit Auswaschschutz
PCT/EP2017/068592 WO2018059786A1 (fr) 2016-09-30 2017-07-24 Agents de traitement capillaire à effet conditionnant amélioré et résistants au lavage

Publications (1)

Publication Number Publication Date
EP3518871A1 true EP3518871A1 (fr) 2019-08-07

Family

ID=59520882

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17748435.9A Withdrawn EP3518871A1 (fr) 2016-09-30 2017-07-24 Agents de traitement capillaire à effet conditionnant amélioré et résistants au lavage

Country Status (4)

Country Link
US (1) US20200030204A1 (fr)
EP (1) EP3518871A1 (fr)
DE (1) DE102016218997A1 (fr)
WO (1) WO2018059786A1 (fr)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3725030A1 (de) 1987-07-29 1989-02-09 Henkel Kgaa Oberflaechenaktive hydroxysulfonate
DE10009439A1 (de) * 2000-02-29 2001-08-30 Schwarzkopf Gmbh Hans Neue Verwendung von kationischen Proteinhydrolysaten
DE10042445A1 (de) * 2000-08-29 2002-03-14 Cognis Deutschland Gmbh Verwendung von quaternierten Proteinhydrolysaten
DE10048922A1 (de) * 2000-10-04 2002-04-11 Henkel Kgaa Neue Verwendung von kurzkettigen Aldehyden und Formaldehyd abspaltenden Verbindungen
DE102009048299A1 (de) 2009-10-05 2011-06-16 Henkel Ag & Co. Kgaa Haarbehandlungsmittel mit Tensid(en) und Proteolipid(en)
DE102014225211A1 (de) * 2014-12-09 2016-06-09 Henkel Ag & Co. Kgaa Leistungsstarke kosmetische Mittel mit Proteolipid und einem Dipeptid
DE102015223828A1 (de) * 2015-12-01 2016-09-15 Henkel Ag & Co. Kgaa Leistungsstarke Haarbehandlungsmittel mit Anti-Auswasch-Effekt

Also Published As

Publication number Publication date
US20200030204A1 (en) 2020-01-30
DE102016218997A1 (de) 2018-04-05
WO2018059786A1 (fr) 2018-04-05

Similar Documents

Publication Publication Date Title
EP3522987A1 (fr) Produits de soin capillaire à effet de conditionnement amélioré assurant une protection contre la perte de couleur
WO2018059766A1 (fr) Produits de soin capillaire à effet de conditionnement amélioré assurant une protection contre la perte de couleur
WO2018059765A1 (fr) Produits de soin capillaire à effet de conditionnement amélioré assurant une protection contre la perte de couleur
EP3519054A1 (fr) Produits de soin capillaire conditionneurs assurant une protection contre la perte de couleur contenant un aldéhyde alpha-substitué
EP3518870A1 (fr) Produits de soin capillaire à effet de conditionnement amélioré assurant une protection contre la perte de couleur
EP3518872A1 (fr) Produits de soin capillaire à effet de conditionnement amélioré assurant une protection contre la perte de couleur
EP3518889A1 (fr) Agents de traitement capillaire à effet conditionnant amélioré et résistants au lavage
WO2018059777A1 (fr) Produits de soin capillaire à effet de conditionnement amélioré assurant une protection contre la perte de couleur
EP3518881A1 (fr) Produits de soin capillaire à effet de conditionnement amélioré assurant une protection contre la perte de couleur
EP3519059A1 (fr) Produits de soin capillaire à effet de conditionnement amélioré assurant une protection contre la perte de couleur
WO2018059786A1 (fr) Agents de traitement capillaire à effet conditionnant amélioré et résistants au lavage
WO2018059780A1 (fr) Produits de soin capillaire à effet de conditionnement amélioré assurant une protection contre la perte de couleur
WO2018059788A1 (fr) Agents de traitement capillaire à effet conditionnant amélioré et résistants au lavage
EP3519053A1 (fr) Produits de soin capillaire à effet de conditionnement amélioré assurant une protection contre la perte de couleur
DE102015223816A1 (de) Leistungsstarke Haarbehandlungsmittel mit strukturstärkendem-Effekt
WO2018059773A1 (fr) Produits de soin capillaire à effet de conditionnement amélioré assurant une protection contre la perte de couleur
EP3518884A1 (fr) Agents de traitement capillaire à effet conditionnant amélioré et résistants au lavage
DE102015223819A1 (de) "Leistungsstarke Haarbehandlungsmittel mit Anti-Auswasch-Effekt "
DE102015223821A1 (de) "Leistungsstarke Haarbehandlungsmittel mit strukturstärkendem-Effekt"

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190218

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20210202